Riskpilot← Back to searchSign inGet full accessBioNema AB
ABActiveOrg 5566141536Överboda 321Manufacture of pesticides, disinfectants and other agrochemical products · NACE 2020Est. 20012 employees
Revenue 2024
SEK 3,9M
+20% vs 2023
EBITDA margin
31.1%
+222% vs 2023
Equity ratio
90.1%
Financial strength
Net profit 2024
SEK 912K
+267% vs 2023
| Revenue | SEK 3,9M | +20% |
| EBITDA | SEK 1,2M | +222% |
| Net profit | SEK 912K | +267% |
| Total assets | SEK 3,2M | +29% |
| Equity | SEK 2,8M | +33% |
| Employees | 2 | — |
Legal name
BioNema AB
Org number
5566141536
Legal form
Aktiebolag
NACE code
2020 · Manufacture of pesticides, disinfectants and other agrochemical products
Founded
17 augusti 2001
Share capital
SEK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är driva utveckling, produktion och försäljning av nematoder och därmed förenlig verksamhet.
Address
Överboda 321
Phone
+4690197640
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 3 736 | 3 481 | 2 545 | 3 237 | 3 879 |
| Staff expenses | — | — | −563 | −472 | −610 |
| EBITDA | 1 184 | 1 179 | 424 | 376 | 1 208 |
| Depreciation & amort. | −100 | −92 | −92 | −83 | −83 |
| EBIT | 1 084 | 1 087 | 332 | 293 | 1 125 |
| Net financials | −1 | −1 | −4 | 21 | 24 |
| Profit before tax | 957 | 848 | 858 | 314 | 1 149 |
| Tax | −206 | −176 | −181 | −65 | −237 |
| Net profit | 751 | 672 | 676 | 248 | 912 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 745 | 2 620 | 2 275 | 2 441 | 3 156 |
| Equity | 1 103 | 1 592 | 2 081 | 2 135 | 2 843 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 350 | 499 | 193 | 306 | 313 |
| Total debt | 350 | 499 | 193 | 306 | 313 |
EBITDA margin
31.1%
This company
15.8%
Market median
+97% vs market
20202024
Equity ratio
90.1%
This company
38.2%
Market median
+136% vs market
20202024
Return on equity
32.1%
This company
18.4%
Market median
+74% vs market
20202024
Net profit margin
23.5%
This company
8.1%
Market median
+190% vs market
20202024
Asset turnover
1.23×
This company
1.12×
Market median
+10% vs market
20202024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (6) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BioNema AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Rolf Tobias Jonsson | Deputy Board Member | 0 companies |
| Gustav Emanuel Jonsson | Deputy Board Member | 0 companies |
| Emmy Malin Sofia Jonsson | Deputy Board Member | 0 companies |
| Elin Maria Christina Hasbany | Deputy Board Member | 0 companies |
| Sandra Linnea Nilsson | Deputy Board Member | 0 companies |
| Susanne Christina Jonsson | Board of Directors | 0 companies |